·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊÆ÷ÀÎÆ®¸ôTVÆʵµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ Çѹ̾àÇ°, ¾È°ú ½Å¾à 'Áß±¹ ÆDZÇÀÌÀü'¡¦1730¾ï ±Ô¸ð ±â»çÀÔ·Â : 22.01.03 08:27:14 0 °¡ ÇÃÄ£Ãß°¡ ¿¡ÆÛ¸Þµå Å׶óǻƽ½º¿Í ¶óÀ̼±½º °è¾à Áß±¹ Á¦Ç° ¹ß¸Å½Ã µÎÀÚ¸´¼ö ·Î¿Æ¼ ¼ö·É [µ¥Àϸ®ÆÊ=À̼®ÁØ ±âÀÚ] Çѹ̾àÇ°Àº '¿¡ÆÛ¸Þµå Å׶óǻƽ½º'¿¡ '¸®¼öÅ×°¡´Õ(Á¦Ç°¸í ·ç¹Ì³×ÀÌÆ®)' Áß±¹ ÆÇ±Ç ÀÌÀü °è¾àÀ» ü°áÇß´Ù°í 3ÀÏ ¹àÇû´Ù. ¿¡ÆÛ¸Þµå´Â ±Û·Î¹ú ÀÓ»ó ´Ü°è ¹ÙÀÌ¿À ÀǾàÇ° Àü¹® ±â¾÷ÀÌ´Ù. '¸®¼öÅ×°¡´Õ'Àº Çѹ̾àÇ°ÀÌ Àü·«Àû ÅõÀÚ¸¦ ´ÜÇàÇÑ ¹Ì±¹ ¾È°úÀü¹® R&D ±â¾÷ ¾Ë·¹±×·Î(Allegro Ophthalmics LLC)°¡ °³¹ßÇÑ ¸Á¸·Áúȯ ºÐ¾ß ½Å¾àÀÌ´Ù. Çѹ̾àÇ°Àº Çѱ¹°ú Áß±¹¿¡¼ °³¹ß ¹× µ¶Á¡ ÆǸűÇÀ» º¸À¯Çß´Ù. Çѹ̾àÇ°Àº °è¾à¿¡ µû¶ó ¿¡Æ۸޵尡 ÁßȱÇ(Áß±¹, È«Äá, ´ë¸¸, ¸¶Ä«¿À)¿¡¼ °Ç¼º³ëÀμºÈ²¹Ýº¯¼º ¹× ±âŸ vitreo-retinal Áúº´ÀÇ Ä¡·á¿¡ Àû¿ëÇÒ ¼ö ÀÖ´Â ¾È°ú ÁÖ»çÁ¦ ¸®¼öÅ×°¡´ÕÀÇ Á¦Á¶, °³¹ß, »ó¿ëÈ¿¡ ´ëÇÑ µ¶Á¡±ÇÀ» ºÎ¿©ÇÑ´Ù. °è¾à ±Ô¸ð´Â °è¾à±Ý 600¸¸ ´Þ·¯¸¦ Æ÷ÇÔÇØ ÇâÈÄ ÀÓ»ó½ÃÇè°ú ½ÃÆÇÇã°¡ µî¿¡ ¼º°øÇÒ °æ¿ì ¹Þ°Ô µÇ´Â ´Ü°èº° ¸¶ÀϽºÅæ ÃÑ 1¾ï4500¸¸ ´Þ·¯(¾à 1730¾ï¿ø)´Ù. Çѹ̾àÇ°Àº Áß±¹¿¡¼ Á¦Ç°ÀÌ Ãâ½ÃµÇ¸é µÎ ÀÚ¸´¼ö ÆÛ¼¾Æ®ÀÇ ÆǸŠ·Î¿Æ¼µµ º°µµ·Î ¹Þ´Â´Ù. À̼®ÁØ ±âÀÚ(wiviwivi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç [Á¦Á¶°ü¸®¾à»ç/Ç°Áú°ü¸®¾à»ç]Áß°ßÁ¦¾à»ç(ÆòÅÃ) ¹Ù·Î°¡±â Sr. RA Specialist, RA Speaiclist ä¿ë ¹Ù·Î°¡±â Ç°Áú°ü¸®¾à»ç / Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â µµ¸Å»ó °ü¸® ¾à»ç´Ô ¸ð½Ê´Ï´Ù. ¹Ù·Î°¡±â [CSL Behring] Marketing Product Manager ¹Ù·Î°¡±â Senior Clinical Research Associate ¹Ù·Î°¡±â Medical ¹× Clinical °¢ ºÎ¹® ä¿ë ¹Ù·Î°¡±â µ¿±¹»ý¸í°úÇÐ(ÁÖ) ¸¶ÄÉÆà ¾à»ç ¹× ¿¬±¸°³¹ß ¾à»ç ¿Ü ä¿ë ¹Ù·Î°¡±â µµ¸Å¾à»ç´Ô ¸ð½Ê´Ï´Ù ¹Ù·Î°¡±â [CSL Behring] Medical Representative ¹Ù·Î°¡±â HLBÁ¦¾à ¾à»ç(RA) ä¿ë ¹Ù·Î°¡±â 2024³â »ó¹Ý±â ¼ö½Ãä¿ë ¹Ù·Î°¡±â BD¶óÀ̼¾½ÌÆÀ ½ÅÀÔ/°æ·Â»ç¿ø ¸ðÁý ¹Ù·Î°¡±â 2024³â Á¦3Â÷ Á÷¿øä¿ë Àç°ø°í ¹Ù·Î°¡±â Medical Communication & Strategy ¹Ù·Î°¡±â µðÁöÅÐÇコÄɾî / Market Access / OTC¸¶ÄÉÆà / ÀÇ·á±â±â ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : Çѹ̾àÇ°, ¾È°ú ½Å¾à Áß±¹ ÆDZÇÀÌÀü¡¦1730¾ï ±Ô¸ð URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ Çѹ̾àÇ°, ¾È°ú ½Å¾à 'Áß±¹ ÆDZÇÀÌÀü'¡¦1730¾ï ±Ô¸ð ±â»çÀÔ·Â : 22.01.03 08:27:14 0 °¡ ÇÃÄ£Ãß°¡ ¿¡ÆÛ¸Þµå Å׶óǻƽ½º¿Í ¶óÀ̼±½º °è¾à Áß±¹ Á¦Ç° ¹ß¸Å½Ã µÎÀÚ¸´¼ö ·Î¿Æ¼ ¼ö·É [µ¥Àϸ®ÆÊ=À̼®ÁØ ±âÀÚ] Çѹ̾àÇ°Àº '¿¡ÆÛ¸Þµå Å׶óǻƽ½º'¿¡ '¸®¼öÅ×°¡´Õ(Á¦Ç°¸í ·ç¹Ì³×ÀÌÆ®)' Áß±¹ ÆÇ±Ç ÀÌÀü °è¾àÀ» ü°áÇß´Ù°í 3ÀÏ ¹àÇû´Ù. ¿¡ÆÛ¸Þµå´Â ±Û·Î¹ú ÀÓ»ó ´Ü°è ¹ÙÀÌ¿À ÀǾàÇ° Àü¹® ±â¾÷ÀÌ´Ù. '¸®¼öÅ×°¡´Õ'Àº Çѹ̾àÇ°ÀÌ Àü·«Àû ÅõÀÚ¸¦ ´ÜÇàÇÑ ¹Ì±¹ ¾È°úÀü¹® R&D ±â¾÷ ¾Ë·¹±×·Î(Allegro Ophthalmics LLC)°¡ °³¹ßÇÑ ¸Á¸·Áúȯ ºÐ¾ß ½Å¾àÀÌ´Ù. Çѹ̾àÇ°Àº Çѱ¹°ú Áß±¹¿¡¼ °³¹ß ¹× µ¶Á¡ ÆǸűÇÀ» º¸À¯Çß´Ù. Çѹ̾àÇ°Àº °è¾à¿¡ µû¶ó ¿¡Æ۸޵尡 ÁßȱÇ(Áß±¹, È«Äá, ´ë¸¸, ¸¶Ä«¿À)¿¡¼ °Ç¼º³ëÀμºÈ²¹Ýº¯¼º ¹× ±âŸ vitreo-retinal Áúº´ÀÇ Ä¡·á¿¡ Àû¿ëÇÒ ¼ö ÀÖ´Â ¾È°ú ÁÖ»çÁ¦ ¸®¼öÅ×°¡´ÕÀÇ Á¦Á¶, °³¹ß, »ó¿ëÈ¿¡ ´ëÇÑ µ¶Á¡±ÇÀ» ºÎ¿©ÇÑ´Ù. °è¾à ±Ô¸ð´Â °è¾à±Ý 600¸¸ ´Þ·¯¸¦ Æ÷ÇÔÇØ ÇâÈÄ ÀÓ»ó½ÃÇè°ú ½ÃÆÇÇã°¡ µî¿¡ ¼º°øÇÒ °æ¿ì ¹Þ°Ô µÇ´Â ´Ü°èº° ¸¶ÀϽºÅæ ÃÑ 1¾ï4500¸¸ ´Þ·¯(¾à 1730¾ï¿ø)´Ù. Çѹ̾àÇ°Àº Áß±¹¿¡¼ Á¦Ç°ÀÌ Ãâ½ÃµÇ¸é µÎ ÀÚ¸´¼ö ÆÛ¼¾Æ®ÀÇ ÆǸŠ·Î¿Æ¼µµ º°µµ·Î ¹Þ´Â´Ù. À̼®ÁØ ±âÀÚ(wiviwivi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç [Á¦Á¶°ü¸®¾à»ç/Ç°Áú°ü¸®¾à»ç]Áß°ßÁ¦¾à»ç(ÆòÅÃ) ¹Ù·Î°¡±â Sr. RA Specialist, RA Speaiclist ä¿ë ¹Ù·Î°¡±â Ç°Áú°ü¸®¾à»ç / Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â µµ¸Å»ó °ü¸® ¾à»ç´Ô ¸ð½Ê´Ï´Ù. ¹Ù·Î°¡±â [CSL Behring] Marketing Product Manager ¹Ù·Î°¡±â Senior Clinical Research Associate ¹Ù·Î°¡±â Medical ¹× Clinical °¢ ºÎ¹® ä¿ë ¹Ù·Î°¡±â µ¿±¹»ý¸í°úÇÐ(ÁÖ) ¸¶ÄÉÆà ¾à»ç ¹× ¿¬±¸°³¹ß ¾à»ç ¿Ü ä¿ë ¹Ù·Î°¡±â µµ¸Å¾à»ç´Ô ¸ð½Ê´Ï´Ù ¹Ù·Î°¡±â [CSL Behring] Medical Representative ¹Ù·Î°¡±â HLBÁ¦¾à ¾à»ç(RA) ä¿ë ¹Ù·Î°¡±â 2024³â »ó¹Ý±â ¼ö½Ãä¿ë ¹Ù·Î°¡±â BD¶óÀ̼¾½ÌÆÀ ½ÅÀÔ/°æ·Â»ç¿ø ¸ðÁý ¹Ù·Î°¡±â 2024³â Á¦3Â÷ Á÷¿øä¿ë Àç°ø°í ¹Ù·Î°¡±â Medical Communication & Strategy ¹Ù·Î°¡±â µðÁöÅÐÇコÄɾî / Market Access / OTC¸¶ÄÉÆà / ÀÇ·á±â±â ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : Çѹ̾àÇ°, ¾È°ú ½Å¾à Áß±¹ ÆDZÇÀÌÀü¡¦1730¾ï ±Ô¸ð URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ Çѹ̾àÇ°, ¾È°ú ½Å¾à 'Áß±¹ ÆDZÇÀÌÀü'¡¦1730¾ï ±Ô¸ð ±â»çÀÔ·Â : 22.01.03 08:27:14 0 °¡ ÇÃÄ£Ãß°¡ ¿¡ÆÛ¸Þµå Å׶óǻƽ½º¿Í ¶óÀ̼±½º °è¾à Áß±¹ Á¦Ç° ¹ß¸Å½Ã µÎÀÚ¸´¼ö ·Î¿Æ¼ ¼ö·É [µ¥Àϸ®ÆÊ=À̼®ÁØ ±âÀÚ] Çѹ̾àÇ°Àº '¿¡ÆÛ¸Þµå Å׶óǻƽ½º'¿¡ '¸®¼öÅ×°¡´Õ(Á¦Ç°¸í ·ç¹Ì³×ÀÌÆ®)' Áß±¹ ÆÇ±Ç ÀÌÀü °è¾àÀ» ü°áÇß´Ù°í 3ÀÏ ¹àÇû´Ù. ¿¡ÆÛ¸Þµå´Â ±Û·Î¹ú ÀÓ»ó ´Ü°è ¹ÙÀÌ¿À ÀǾàÇ° Àü¹® ±â¾÷ÀÌ´Ù. '¸®¼öÅ×°¡´Õ'Àº Çѹ̾àÇ°ÀÌ Àü·«Àû ÅõÀÚ¸¦ ´ÜÇàÇÑ ¹Ì±¹ ¾È°úÀü¹® R&D ±â¾÷ ¾Ë·¹±×·Î(Allegro Ophthalmics LLC)°¡ °³¹ßÇÑ ¸Á¸·Áúȯ ºÐ¾ß ½Å¾àÀÌ´Ù. Çѹ̾àÇ°Àº Çѱ¹°ú Áß±¹¿¡¼ °³¹ß ¹× µ¶Á¡ ÆǸűÇÀ» º¸À¯Çß´Ù. Çѹ̾àÇ°Àº °è¾à¿¡ µû¶ó ¿¡Æ۸޵尡 ÁßȱÇ(Áß±¹, È«Äá, ´ë¸¸, ¸¶Ä«¿À)¿¡¼ °Ç¼º³ëÀμºÈ²¹Ýº¯¼º ¹× ±âŸ vitreo-retinal Áúº´ÀÇ Ä¡·á¿¡ Àû¿ëÇÒ ¼ö ÀÖ´Â ¾È°ú ÁÖ»çÁ¦ ¸®¼öÅ×°¡´ÕÀÇ Á¦Á¶, °³¹ß, »ó¿ëÈ¿¡ ´ëÇÑ µ¶Á¡±ÇÀ» ºÎ¿©ÇÑ´Ù. °è¾à ±Ô¸ð´Â °è¾à±Ý 600¸¸ ´Þ·¯¸¦ Æ÷ÇÔÇØ ÇâÈÄ ÀÓ»ó½ÃÇè°ú ½ÃÆÇÇã°¡ µî¿¡ ¼º°øÇÒ °æ¿ì ¹Þ°Ô µÇ´Â ´Ü°èº° ¸¶ÀϽºÅæ ÃÑ 1¾ï4500¸¸ ´Þ·¯(¾à 1730¾ï¿ø)´Ù. Çѹ̾àÇ°Àº Áß±¹¿¡¼ Á¦Ç°ÀÌ Ãâ½ÃµÇ¸é µÎ ÀÚ¸´¼ö ÆÛ¼¾Æ®ÀÇ ÆǸŠ·Î¿Æ¼µµ º°µµ·Î ¹Þ´Â´Ù. À̼®ÁØ ±âÀÚ(wiviwivi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : Çѹ̾àÇ°, ¾È°ú ½Å¾à Áß±¹ ÆDZÇÀÌÀü¡¦1730¾ï ±Ô¸ð URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö